| 000 | 02923cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223032520.0 | ||
| 008 | 200205s2019 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.04.M.Sc.2019.Mu.C | ||
| 100 | 0 | _aMuhammad Adel Muhammad Ali | |
| 245 | 1 | 0 |
_aClinical and oncological outcomes of borderline ovarian tumors / _cMuhammad Adel Muhammad Ali ; Supervised Mohamed Abdelfattah Elzohairy , Nesreen Hassan Hafez , Amr Kamal Mohamed |
| 246 | 1 | 5 | _aالنتائج الإكلينيكية والسرطانية لأورام المبيض البينية |
| 260 |
_aCairo : _bMuhammad Adel Muhammad Ali , _c2019 |
||
| 300 |
_a98 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Surgical) | ||
| 520 | _aIn the current study, we report our experience with borderline ovarian tumors, and include a summary of the current literature to provide a reference for the management of this disease. We collected and analyzed retrospective data on the pathology, management, disease free survival (DFS) of patients with BOTs who underwent surgical management at or were referred to department of surgical oncology, National Cancer Institute, Cairo University (NCI) from January 2013 to December 2017. This retrospective cohort study included 69 cases.The mean age of our patients at the time of surgery is 41.3 years with 52.17 % of them below the age of 40. The most common stage of the disease was stage IA and only two cases developed metastasis. Serous BOT was the most common pathology followed by mucinous BOT. The most common surgical complication was ureteric injury. Bilateral tumors were found in 27.5 % of cases. 4 patients underwent fertility sparing surgery via laparoscopy. 10.1 % of cases received adjuvant chemotherapy. 50.7 % of cases underwent fertility sparing surgery, while radical surgery was performed for 49.3 %. Higher recurrence rate was found in the fertility sparing group. All patients who underwent fertility sparing surgery had normal menstrual cycle. Successful pregnancy occurred in 41.1 % of patients who desired fertility after surgery. Overall disease-free survival (DFS) was 90.164 months. The most important prognostic factors were disease stage, presence of peritoneal implants and surgical approach | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAmerican Joint Committee on Cancer (AJCC ) | |
| 653 | 4 | _aBorderline Ovarian Tumors (BOTs) | |
| 653 | 4 | _aBreast Cancer gene (BRCA) | |
| 700 | 0 |
_aAmr Kamal Mohamed , _eSupervisor |
|
| 700 | 0 |
_aMohamed Abdelfattah Elzohairy , _eSupervisor |
|
| 700 | 0 |
_aNesreen Hassan Hafez , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aShimaa _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c76526 _d76526 |
||